Exam 1 Flashcards
Important characteristics of receptors
- bind due to high affinity, so low amount of drug is required to cause an effect and the effect will take longer to end
- effect depends on the drug that binds to the receptor
Law of mass action as it pertains to drug binding
Doesn’t matter how much is given, drug effect is proportional to how much drug bind to receptors (Kd)
Kd
- Dissociation constant ([D][R])
- Kd is the drug concentration needed to bind 50% of receptors
- Measures affinity/potency of a drug
- Fraction of the receptor bound (bound receptors/ total receptors)
EC__
Effective concentration to see ___% of max effect
Which is more potent? Smaller or bigger Kd?
Smaller - will bind to receptor longer, thus act for longer time
Potency
Compares drug concentrations needed to get 50% of max effect (EC50)
Efficacy
Measures maximal effect (because not all drugs achieve max activation of receptors)
Full agonist
Causes max activation of receptors at a high dose
Partial agonist
Does not achieve max activation of receptors at a high dose (less efficacious drug)
Which is more important: Efficacy or potency?
Efficacy
Less potent drug with high efficacy = better results than high potency, less efficacious drug
Buprenorphine vs. Morphine
B - potent, partial agnoist with high affinity binding (so smaller dose will cause moderate analgesic effect, but it lasts longer) (if follow with morphine, B won’t dissociate, so likely will just have moderate pain relief)
M - less potent full agonist with lower affinity binding (so doesn’t last as long, but stronger analgesic effect)
Agonist
Has an effect on the receptor
Antagonist
Binds to receptor but doesn’t have an effect, blocks effect of agonist
Alone, doesn’t cause a dose response curve/effect, just flat horizontal line
What if an agonist and a competitive antagonist are both given?
Dose response curve shifts to right
Greater dose of agonist required to get same effect
What if an agonist and a non-competitive antagonist are both given?
Dose response curve is shorter/pushed down (decreased max effect) - agonist is made less efficacious (still binds but antagonist still stops receptor from responding)
Classes of signal transduction pathways
Ionotropic (ion channels, fast)
Metabotropic (G-prot)
Transcription Factors (change gene expression)
Enzyme-linked
Name 3 situations where drug binding to receptor isn’t proportional to drug effect
- 2nd messenger cascades
- Spare receptors
- Tolerance/desensitization
Spare receptors
Max response occurs even when agonist doesn’t fully occupy all available receptors (e.g. NMJ)
-alters dose response curve
Tolerance/desensitization
- previous/repeated exposure to drug may increases tolerance, decreasing drug effect
- partly due to a decrease in number of receptors
Partial agonist
Less efficacious, induce partial (non-max) activation when bind to receptor
Naloxone
- potent, partial opioid antagonist
- reversal for morphine or buprenorphine
- will reverse morphine faster than buprenorphine
Complex model of receptor binding
- some receptors shift between active/inactive without binding of drug to stimulate shift
- Assume some receptors are active without having bound drug
- drug binding will “stabilize” receptors by causing them to remain in active or inactive state
Inverse agonist
- binds to same receptor as agonist, but stabilizes it as inactive
- reduces effect opposite that of the agonist
How do spare receptors affect ED/C50
- EC50 will be lower than Kd
- with more spare receptors, a lower concentration will cause effect
Quantal/Population cumulative distribution curve
- not a true dose response curve
- curve made based on frequency distributions seen in a population
- measures if animal responded to drug or didn’t at each point
- NO predictive value to graph
use of population curves for toxicity studies
Used to estimate drug safety by determining therapeutic index
Therapeutic index
LD50/ED50 = TI
Compares dose/concentration that causes effect with dose/concentration that causes toxic effect
What therapeutic index number is considered safe?
> 10
larger TI = safer drug
Standard safety margin
% by which the ED99 must be increased before an LD1 is reached
Therapeutic window
Window where many patients get a good response and only a few toxic effects occur
Tachyphylaxis
acute drug desensitization
occurs after initial dose or after series of small doses
Down regulation
A decrease in the number of receptors responding to a drug, making cells less sensitive to the drug
What determines drug concentration?
drug (g) / volume (l)
Central compartment organs
- brain, spinal cord, retina
- well perfused, drug has rapid effects
Peripheral compartment organs
- skin, muscle, fat
- not well perfused, drug has slower effects
Advantages of parenteral drug administration (vs. oral)
-avoids lack of uptake issues with GI
-avoids elimination by the liver
aka you know it’s in there
-rate of uptake into blood usually faster
Advantages of oral drug administration (vs. parenteral)
-rate of uptake into blood usually slower
IV administration
- absorption circumvented
- fast
- provides bolus
- constant rate of infusion leading to steady state
- can give irritating solutions (b/c rapid dilution) or large volumes
- don’t give oils or suspensions
Bolus
Initial spike of drug into blood
Drug in central compartment first, then rapidly moves to peripheral
Once in peripheral compartment, slow decrease b/c removed only by elimination
steady state
- constant level of drug in the blood
- Only at this state does animal get full benefit of the drug.
Subcu administration
- aqueous solutions absorbed promptly
- repository, slow sustained release
- don’t give large vol, irritants